Guess what, barely a week later, Malaysian Deputy Prime Minister Najib Razak witnessed the signing of “Memorandum of Understanding” (MOU) between Malaysian Biotechnology Corporation and the Manipal Group at Boston (Najib is there for the annual BIO International Convention). India’s Manipal Education and Medical Group are expected to be set up in Malaysia to focus on stem cell research and development.
Another significant MoU will be between Massachusetts Institute of Technology and the National Biotechnology Division of the Science, Technology and Innovation Ministry. Meanwhile another agreement involves Inno Biologics Sdn Bhd which will sign a 10-year cooperation with Boehringer Ingelheim of Germany to allow Inno Biologics to have access to its technology for the manufacturing of biopharmaceutical products.
Aren’t you puzzle with Malaysian Government who is trying very hard to tell the world that the country is on its way to be a Bio-Tech center but on the other hand the Health Minister said it was a “hype” and there’re no medical evidence to the use of the blood’s stem cells for treatment of diseases and conditions.
So, why sign the MOU at the first place since it’s a useless research? Either Malaysian Government is smart in conning Indian business enrity into setting up the research in Malaysia or the Indian’s Manipal Group is stupid enough to pour money into something which has been said to be “hype.” Hey isn’t that the same?
Hmm, let’s put it in another way. Either Dr Chua is smart enough to tell all the Malaysian (including the Ministers) that the stem cell research is a waste of time and money or Najib is idiot enough not to listen to the wise-advice from the Health Minister.
Whatever the intention, I still believe it’ll be a non-event and non-achievement to Malaysia as there’re simply no human-capital in this sector. I still can remember 15 years back when some of my friends told me how he pity the Malaysian students who have finished their study majoring in Bio-Tech but couldn’t’ find a job. The result – most of these bright students ended up next door, to Singapore. Isn’t it funny that while Malaysian Government is screaming proudly and arrogantly about Bio-Tech, the Singapore Government has been quietly importing Malaysian’s brain into developing their now-massive Bio-Tech industry? Who is the smarter one?
I wonder what’s the stock price for StemLife Berhad (KLSE: STEMLFE, stock-code 0137) and TMC Life Sciences Bhd (KLSE: TMCLIFE, stock-code 0101) now.
Yes, Singapore has done a great, great deal in pushing their biotechnology. They have spent big, big monies recruiting some of the very best in the field from the UK, US, and Japan. Even the professor who cloned Dolly the Sheep is now working in Singapore. When it comes to vision, strategic planning, and execution, there’s still a lot for the Malaysian government to learn.
I believe in the potential of stem cell. I think what concerns Dr Chua is how the business is being conducted. Maybe the sales person promised earth and heaven, make everything sounds so positive it becomes a craze just like the tulip.
swifz, i agreed that the sales reps could be the culprit but for a health minister to dismiss the other potential of stem cell is equivalent to totally shootdown the probably only-life-safer option public has …
you’ll never know what your stem-cell can do to your current baby 10 years down the road …
as a minister he shouldn’t use the word “hype” – instead he should get clarification from the storage provider if there’re indeed irresponsible sales persons who promised the sky …
just imagine parents who initially decided to store their new-born baby’s cord only to throw it away because of the minister’s statement …
cheers …
Comment by sudeshion September 16, 2007 at 10:25 am
I believe the Indian govt is not involved in this. Read the news once again, you will realise this. Manipal Education Group is a private entity and is not concerned in any way with the Govt of India. So if Manipal is fooled into investing in Malaysia, it is their folly, not Indian Govt’s folly. Kindly rephrase your blog entry.
Yes, Singapore has done a great, great deal in pushing their biotechnology. They have spent big, big monies recruiting some of the very best in the field from the UK, US, and Japan. Even the professor who cloned Dolly the Sheep is now working in Singapore. When it comes to vision, strategic planning, and execution, there’s still a lot for the Malaysian government to learn.